Chem Structure (Labetalol Tabs 8512 8513 1)
Labetalol Hydrochloride Tablet, Film Coated
Product Images NDC 0615-8513
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 0615-8513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (Labetalol Tabs 8512 8513 2)
This is a product description for Labetalol Hydrochloride Tablets, USP 100 mg. The tablets are packaged by Vangard and Glasglow for Biocon Pharma. Each tablet contains 100 mg of labetalol hydrochloride, USP. The usual dosage can be found in the package insert. The tablets should be stored at 20°C to 25°C (68°F to 77°F). It is indicated for institutional use only.*
Principal Display Panel (Labetalol Tabs 8512 8513 3)
This is a description of a medication packaging for Labetalol Hydrochloride Tablets, USP 200 mg. The packaging contains information such as the lot number, NDC code, manufacturer details (Appco Pharma for Biocon Pharma), and the storage instructions (20°C to 25°C). The tablets are indicated for institutional use only and each tablet contains 200 mg of Labetalol Hydrochloride, USP. The package insert should be referred to for full prescribing information and usual dosage. The tablets are intended for use in a healthcare setting or institution.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
